Transcriptome adaptation of group B Streptococcus to growth in human amniotic fluid

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Sitkiewicz, Izabela ^a,c   Green, Nicole M ^a   Guo, Nina ^a   Bongiovanni, Ann Marie ^b   Witkin, Steven S ^b   Musser, James M ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; HEMOLYSIN; INTERLEUKIN 8; PROTEINASE; TRANSCRIPTOME; MESSENGER RNA;

AMINO ACID METABOLISM; AMNION FLUID; ARTICLE; BACTERIAL GROWTH; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; EMBRYO; FEMALE; GENETIC TRANSCRIPTION; GROUP B STREPTOCOCCAL INFECTION; GROWTH CURVE; HOST PATHOGEN INTERACTION; HUMAN; HYBRIDIZATION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; NUTRITIONAL REQUIREMENT; RNA ISOLATION; STREPTOCOCCUS AGALACTIAE; VIRULENCE; BACTERIAL GENE; CULTURE MEDIUM; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

AMNIOTIC FLUID; CARBOHYDRATE METABOLISM; CULTURE MEDIA; GENE EXPRESSION PROFILING; GENES, BACTERIAL; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 67749120526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006114     Document Type: Article

References (46)

1. Shet A, Ferrieri P (2004) Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian J Med Res 120: 141-150.
2. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, et al. (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299: 2056-2065.
3. Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, et al. (1993) A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 328: 1807-1811.
4. Schuchat A, Wenger JD (1994) Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev 16: 374-402.
5. Sitkiewicz I, Musser JM (2009) Analysis of growth-phase regulated genes in Streptococcus agalactiae by global transcript profiling. BMC Microbiology 9: 32.
6. Mereghetti L, Sitkiewicz I, Green NM, Musser JM (2008) Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS ONE 3: e2785.
7. Mereghetti L, Sitkiewicz I, Green NM, Musser JM (2008) Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B Streptococcus) in response to incubation with human blood. Plos ONE 3(9): e3143.
8. Graham MR, Virtaneva K, Porcella SF, Barry WT, Gowen BB, et al. (2005) Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 166: 455-465.
9. Shelburne SA 3rd, Sumby P, Sitkiewicz I, Granville C, DeLeo FR, et al. (2005) Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A 102: 16037-16042.
10. Glaser P, Rusniok C, Buchrieser C, Chevalier F, Frangeul L, et al. (2002) Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 45: 1499-1513.
11. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
12. Sitkiewicz I, Musser JM (2006) Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a Streptococcus. Infect Immun 74: 1339-1351.
13. Shelburne SA 3rd, Keith D, Horstmann N, Sumby P, Davenport MT, et al. (2008) A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc Natl Acad Sci U S A 105: 1698-1703.
14. Scane TM, Hawkins DF (1984) Antibacterial activity in human amniotic fluid: relationship to zinc and phosphate. Br J Obstet Gynaecol 91: 342-348.
15. Scane TM, Hawkins DF (1986) Antibacterial activity in human amniotic fluid: dependence on divalent cations. Br J Obstet Gynaecol 93: 577-581.
16. Larsen B, Hurry DJ, Miro RE, Charles D (1983) Antibacterial activity in amniotic fluid from west virginia women. Gynecol Obstet Invest 15: 26-32.
17. Mathai M, Jairaj P, Thangavelu CP, Mathai E, Balasubramaniam N (1984) Antimicrobial activity of amniotic fluid in South Indian women. Br J Obstet Gynaecol 91: 560-564.
18. Nazir MA, Pankuch GA, Botti JJ, Appelbaum PC (1987) Antibacterial activity of amniotic fluid in the early third trimester. Its association with preterm labor and delivery. Am J Perinatol 4: 59-62.
19. Hagio Y (1985) [Antibacterial activity of amniotic fluid and lysozyme]. Nippon Sanka Fujinka Gakkai Zasshi 37: 2369-2375.
20. Appelbaum PC, Holloway Y, Ross SM, Dhupelia I (1977) The effect of amniotic fluid on bacterial growth in three population groups. Am J Obstet Gynecol 128: 868-871.
21. Evans HE, Levy E, Glass L (1977) Effect of amniotic fluid on bacterial growth. Obstet Gynecol 49: 35-37.
22. Malke H, Steiner K, McShan WM, Ferretti JJ (2006) Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int J Med Microbiol 296: 259-275.
23. Hendriksen WT, Bootsma HJ, Estevao S, Hoogenboezem T, de Jong A, et al. (2008) CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization. J Bacteriol 190: 590-601.
24. Malke H, Ferretti JJ (2007) CodY-affected transcriptional gene expression of Streptococcus pyogenes during growth in human blood. J Med Microbiol 56: 707-714.
25. Lamy MC, Zouine M, Fert J, Vergassola M, Couve E, et al. (2004) CovS/ CovR of group B Streptococcus: a two-component global regulatory system involved in virulence. Mol Microbiol 54: 1250-1268.
26. Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE, et al. (2002) Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci U S A 99: 13855-13860.
27. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, et al. (2004) Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A 101: 14491-14496.
28. Nizet V (2002) Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol 10: 575-580.
29. Harris TO, Shelver DW, Bohnsack JF, Rubens CE (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111: 61-70.
30. Sumby P, Zhang S, Whitney AR, Falugi F, Grandi G, et al. (2008) A chemokinedegrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun 76: 978-985.
31. Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, et al. (2005) Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis 192: 783-790.
32. Beckmann C, Waggoner JD, Harris TO, Tamura GS, Rubens CE (2002) Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun 70: 2869-2876.
33. Natanson S, Sela S, Moses AE, Musser JM, Caparon MG, et al. (1995) Distribution of fibronectin-binding proteins among group A streptococci of different M types. J Infect Dis 171: 871-878.
34. Nyberg P, Sakai T, Cho KH, Caparon MG, Fassler R, et al. (2004) Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J 23: 2166-2174.
35. van Scheltema PN, In't Anker PS, Vereecken A, Vandenbussche FP, Deprest JA, et al. (2008) Biochemical composition of fluids for amnioinfusion during fetoscopy. Gynecol Obstet Invest 66: 227-230.
36. Mesavage WC, Suchy SF, Weiner DL, Nance CS, Flannery DB, et al. (1985) Amino acids in amniotic fluid in the second trimester of gestation. Pediatr Res 19: 1021-1024.
37. Cho CK, Shan SJ, Winsor EJ, Diamandis EP (2007) Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 6: 1406-1415.
38. Samen U, Gottschalk B, Eikmanns BJ, Reinscheid DJ (2004) Relevance of peptide uptake systems to the physiology and virulence of Streptococcus agalactiae. J Bacteriol 186: 1398-1408.
39. Darmstadt GL, Mentele L, Podbielski A, Rubens CE (2000) Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun 68: 1215-1221.
40. Loughman JA, Caparon MG (2006) A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J 25: 5414-5422.
41. Pine L, Reeves MW (1972) Correlation of M protein production with those factors found to influence growth and substrate utilization of Streptococcus pyogenes. Infect Immun 5: 668-680.
42. Liu Y, Dong Y, Chen YY, Burne RA (2008) Environmental and growth phase regulation of the arginine deiminase genes of Streptococcus gordonii. Appl Environ Microbiol 74(16): 5023-30.
43. Lin X, Lamont RJ, Wu J, Xie H (2008) Role of differential expression of streptococcal arginine deiminase in inhibition of fimA expression in Porphyromonas gingivalis. J Bacteriol 190: 4367-4371.
44. Chaussee MS, Somerville GA, Reitzer L, Musser JM (2003) Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J Bacteriol 185: 6016-6024.
45. Degnan BA, Palmer JM, Robson T, Jones CE, Fischer M, et al. (1998) Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun 66: 3050-3058.
46. Lei B, Mackie S, Lukomski S, Musser JM (2000) Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect Immun 68: 6807-6818.